The rescission of the 2021 Executive Order on Promoting Competition, coupled with a more permissive tone from the Federal Trade Commission (FTC), marks a pivotal shift in the hospital and health system M&A landscape. While not a full deregulation, this change signals greater flexibility for health systems pursuing strategic growth, consolidation, or restructuring. For executives, this moment presents both a time-sensitive opportunity and a call for disciplined, community-conscious action.
Read the full article: How the Easing of Federal Regulations Is Influencing Health System M&A //
Source: https://guidehouse.com/insights/healthcare/2025/healthcare-ma-regulations